MOUSE MONOCLONAL IGG3 ANTIBODY DETECTING GD3 GANGLIOSIDE - A PHASE-I TRIAL IN PATIENTS WITH MALIGNANT-MELANOMA

被引：596
|
作者：
HOUGHTON, AN
MINTZER, D
CORDONCARDO, C
WELT, S
FLIEGEL, B
VADHAN, S
CARSWELL, E
MELAMED, MR
OETTGEN, HF
OLD, LJ
机构：
来源：
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | 1985年 / 82卷 / 04期
关键词：
D O I：
10.1073/pnas.82.4.1242
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：1242 / 1246
页数：5
相关论文
共 50 条
  • [31] PHASE-I/II TRIAL OF INTERFERON-ALPHA (RHUIFN-ALPHA-2A) IN COMBINATION WITH AN ANTI-GD3 MONOCLONAL-ANTIBODY (R24) IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA - PRELIMINARY-RESULTS
    MURTHY, S
    BUKOWSKI, RM
    BARNA, B
    CAULFIELD, M
    TUBBS, R
    VALENZUELA, R
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 387 - 387
  • [32] PURIFICATION AND STABILIZATION OF A POORLY SOLUBLE MOUSE IGG3 MONOCLONAL-ANTIBODY
    JISKOOT, W
    HOVEN, AMV
    DEKONING, AAM
    LEERLING, MF
    REUBSAET, CHK
    CROMMELIN, DJA
    BEUVERY, EC
    JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 138 (02) : 181 - 189
  • [33] Compared immunogenicity in mice of GD3 ganglioside purified from human malignant melanoma versus glyco-replica peptides mimicking GD3
    Popa, I
    Ishikawa, D
    Taki, T
    Portoukalian, J
    Thomas, L
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (03) : 521 - 521
  • [34] DISTRIBUTION OF GANGLIOSIDE GD3 IN MALIGNANT-MELANOMA, EPITHELIAL TUMORS AND NORMAL HUMAN-TISSUE, DETERMINED BY IMMUNO-HISTOCHEMICAL STAINING
    DIPPOLD, W
    DIENES, HP
    KNUTH, A
    ZUMBUSCHENFELDE, KHM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 300 - 300
  • [35] DISTRIBUTION OF THE GANGLIOSIDE GD3 IN THE HUMAN NERVOUS-SYSTEM DETECTED BY R24 MOUSE MONOCLONAL-ANTIBODY
    GRAUS, F
    CORDONCARDO, C
    HOUGHTON, AN
    MELAMED, MR
    OLD, LJ
    BRAIN RESEARCH, 1984, 324 (01) : 190 - 194
  • [36] A PHASE-I STUDY OF ANTI-GD3 GANGLIOSIDE MONOCLONAL-ANTIBODY R24 AND RECOMBINANT HUMAN MACROPHAGE-COLONY-STIMULATING FACTOR IN PATIENTS WITH METASTATIC MELANOMA
    MINASIAN, LM
    YAO, TJ
    STEFFENS, TA
    SCHEINBERG, DA
    WILLIAMS, L
    RIEDEL, E
    HOUGHTON, AN
    CHAPMAN, PB
    CANCER, 1995, 75 (09) : 2251 - 2257
  • [37] ANTITUMOR EFFECTS OF A NOVEL MONOCLONAL-ANTIBODY WITH HIGH BINDING-AFFINITY TO GANGLIOSIDE GD3
    OHTA, S
    HONDA, A
    TOKUTAKE, Y
    YOSHIDA, H
    HANAI, N
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1993, 36 (04) : 260 - 266
  • [38] MOUSE MONOCLONAL-ANTIBODIES WITH SPECIFICITY FOR THE MELANOMA-ASSOCIATED GANGLIOSIDE DISIALYLLACTOSYLCERAMIDE (GD3) ALSO REACT WITH THE STRUCTURAL ANALOG DISIALYLPARAGLOBOSIDE
    BRODIN, T
    HELLSTROM, I
    HELLSTROM, KE
    KARLSSON, KA
    SJOGREN, HO
    STROMBERG, N
    THURIN, J
    BIOCHIMICA ET BIOPHYSICA ACTA, 1985, 837 (03) : 349 - 353
  • [39] ENHANCEMENT OF CYTOTOXIC AND PROLIFERATIVE RESPONSES OF LYMPHOCYTES FROM MELANOMA PATIENTS BY INCUBATION WITH MONOCLONAL-ANTIBODIES AGAINST GANGLIOSIDE GD3
    HERSEY, P
    MACDONALD, M
    BURNS, C
    CHERESH, DA
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1987, 24 (02) : 144 - 150
  • [40] Immunization of melanoma patients with BEC2 anti-idiotypic monoclonal antibody that mimics GD3 ganglioside: Enhanced immunogenicity when combined with adjuvant
    McCaffery, M
    Yao, TJ
    Williams, L
    Livingston, PO
    Houghton, AN
    Chapman, PB
    CLINICAL CANCER RESEARCH, 1996, 2 (04) : 679 - 686
12345